National Institute of Allergy and Infectious Diseases director Anthony S. Fauci discussed pandemic preparedness and racial health disparities in a virtual seminar on Thursday hosted by Harvard Medical School’s Francis A. Countway Library of Medicine.
David F. M. Brown, the current chair of Emergency Medicine at Massachusetts General Hospital and professor of emergency medicine at Harvard Medical School, will become the next president of MGH on Sept. 8.
Massachusetts General Hospital, an affiliate of Harvard Medical School, has launched a new center to study the clinical benefits of psychedelics in treating mental illness.
‘Misleading to the Public’: Students, Experts Criticize Harvard Study Suggesting Early Emergence of Covid-19 in Wuhan
A June 2020 research article suggested that the novel coronavirus emerged in Wuhan earlier than the documented start of the pandemic in December 2019. Upon closer examination, two SEAS graduate students found what they believed to be multiple flaws in the presentation and methods of the study.
Peter L. Slavin ’79 will step down as president of Massachusetts General Hospital, a role he has held for the past 18 years, he announced in a message to hospital affiliates Wednesday morning.
In distributing the coronavirus vaccines to healthcare workers, patients, and the public, Harvard’s hospitals and researchers have looked for ways to counter historic inequities. The solutions they come up with could be key to ending the coronavirus pandemic — in Massachusetts and around the world.
Harvard-affiliated hospitals began vaccinating health care workers against Covid-19 in December as hospitals across the country race to shield workers from the infectious disease.
Center for Advanced Biological Innovation and Manufacturing Secures $76 Million in Funding, Signs Lease
The Massachusetts Center for Advanced Biological Innovation and Manufacturing has obtained $76 million in funding and signed a lease for a 40,000-square foot site in Watertown, Mass. for the manufacturing and innovation of new biotechnologies.
Pregnant women infected with SARS-CoV-2 during their third trimester are unlikely to pass on the virus or protective antibodies to their newborn, according to two studies by Harvard Medical School researchers published last month.